Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that low-intensity light therapy improved quality of life related to emotional, psychosocial, and symptom domains in individuals with androgenic alopecia, with a greater impact observed in women.

This case report found that topical Minoxidil was effective and safe in achieving complete hair regrowth for patients experiencing partial or total alopecia during chemotherapy, with no adverse effects observed after three months of treatment.

In this study, patients with alopecia areata who experienced sustained hair regrowth while being treated with baricitinib showed improvements in health-related quality of life and reductions in anxiety and depression symptoms over 104 weeks, according to the BRAVE-AA phase III trials.

In this study, researchers found that systemic lupus erythematosus significantly affects the self-image of many men, impacting their sense of masculinity and self-worth due to physical and psychosocial challenges, while a minority felt no effect.

This article reviews various medical treatments for hidradenitis suppurativa based on the author's experience with over 350 patients, but it reports no new clinical findings.

This study found a high prevalence of stress-related hair loss in Al Majma'ah, Saudi Arabia, particularly among females and individuals aged 31-40, with significant associations between hair loss and stress, psychosocial challenges, and sociodemographic factors.

This study observed that androgenetic alopecia notably impacts quality of life, with women experiencing poorer outcomes than men, particularly affecting symptoms, feelings, and personal relationships.

This study found that late adolescent and young women with clinical hyperandrogenism, including PCOS, experienced higher psychological distress and impaired well-being compared to their healthy peers.

This review in JEADV highlights the systemic causes of hair loss, emphasizing the psychosocial impact of androgenetic alopecia and exploring post-COVID-19 telogen effluvium, while also addressing the treatment safety and challenges in alopecia areata management.

This source provides a comprehensive review of acne vulgaris, highlighting its pathophysiology, epidemiology, molecular mechanisms, and treatment options, emphasizing the significance of addressing acne's psychosocial burden for adolescents and beyond.

This study found that patients with androgenetic alopecia, especially those who are young, less educated, and single, experience significantly reduced health-related quality of life.

This study in Egyptian children found that scalp hair loss significantly impacts quality of life, with nearly half experiencing severe emotional and social challenges, particularly those with alopecia areata and tinea capitis.

This study describes characteristics and outcomes for adults initiating ritlecitinib for severe alopecia areata, highlighting increased hair regrowth and physician satisfaction with longer treatment durations, despite ongoing psychosocial impacts like embarrassment and anxiety among patients.

This study found that alopecia areata and androgenetic alopecia moderately affected the quality of life of Chinese patients, with younger individuals and those experiencing hair loss for over a year reporting higher impact.

In this study on adolescents with severe alopecia areata, baricitinib treatment showed effective scalp, eyebrow, and eyelash regrowth after 52 weeks, benefiting both responders and partial or non-responders, potentially reducing the psychosocial impact of the disease.

This essay illustrates how individual patient choices, alongside advancing treatments, significantly influence alopecia areata management, underscoring the profound effect on patients' quality of life and self-identity.

This review found that despite varied levels of stigmatization reported in studies, hair loss generally leads to stigmatization and a reduced quality of life, but specific research on this stigma is limited.

This review highlights that alopecia areata significantly impacts mental health and finances, with patients facing depression, anxiety, and substantial out-of-pocket expenses due to limited insurance coverage.

This article discusses various forms of hair loss and their psychological impacts, noting the lack of definitive treatments, but reports no new clinical findings.

Male pattern hair loss negatively affects quality of life, but drug treatments can help.

This study found that COVID-19 infection is a frequent cause of acute telogen effluvium, leading to excessive hair loss within 2–3 months after infection.

This case study describes a 15-year-old girl with progressive hair thinning and reduced hair density at the frontal scalp, with a family history of alopecia.

This review discusses evidence-based complementary strategies for enhancing hair regrowth after post-COVID-19 telogen effluvium and reports no new clinical results.

In this case study, the researchers at Dr Batra’s® Homeopathy Clinic reported that an individualized classical homeopathic treatment notably improved hair density, thickness, and scalp health, along with enhancing quality of life, in a middle-aged woman with chronic androgenetic alopecia.

This study found that using calcipotriene and betamethasone dipropionate cream in a real-world setting significantly improved clinical outcomes and patient quality of life for adults with mild-to-moderate scalp psoriasis, especially among those with higher adherence, demonstrating high treatment satisfaction.

People with facial disfigurements are judged more negatively, highlighting the social benefits of corrective surgery.

Hair loss negatively impacts quality of life, and psychological support can help.

This review assessed available treatments for female pattern hair loss and found that minoxidil improved hair regrowth compared to placebo, though high-quality evidence was limited for other interventions.

This study reported a significant relapse in alopecia areata among patients infected with COVID-19, possibly due to the infection's inflammatory response and stress from quarantine.

This study found psychological improvements related to hair problems, social discomfort, and self-esteem were greater in the group using minoxidil for early-stage androgenetic alopecia compared to the placebo group.